A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Pain; Bone Neoplasms; Neoplasm Metastasis
Interventions: DRUG: Ibandronate
Sponsor: Hoffmann-La Roche